Skip to main content
. 2016 Dec 25;8(15):24401–24414. doi: 10.18632/oncotarget.14224

Table 4. CAM use: Association with demographics and disease characteristics.

Variable CAM use p*
YES n= 229(%) NO n= 239(%)
SEX
 male 103(45) 136(56.9) 0.01
 female 126(55) 103(43.1)
Age
 < 40 7(3.1) 16(6.7) < 0.0001
 40 – 70 97(42.4) 148(61.9)
 > 70 125(54.6) 75(31.4)
EDUCATION
 Elementary/middle (< 8 ys) 59(25.8) 119(49.8) < 0.0001
 High/degree (< 8 ys) 170(74.2) 120(50.2)
ORIGIN
 Centre/North 173(75.5) 72(30.1) < 0.0001
 South/Islands 56(24.5) 167(69.9)
ANXIETY
 Often 25(10.9) 47(19.7) < 0.0001
 Sometimes 29(12.7) 53(22.2)
 Never 175(76.4) 139(58.2)
PAIN
 Yes 93(40.6) 57(23.8) < 0.0001
 No 136(59.4) 182(76.2)
HOSPITAL
 Cancer centre 202(88.2) 123(51.5) < 0.0001
 Peripheral hospital/clinic 27(11.8) 116(48.5)
PRIMARY TUMOUR
 Breast 24(10.5) 54(22.6) < 0.0001
 Lung 164(71.6) 58(24.3)
 Colorectal 11(4.8) 45(18.8)
 Gastr/Pancr/HCC/Bil tract 5(2.2) 18(7.5)
 Uro-Gynecology 6(2.6) 20(8.4)
 Other 19(8.3) 44(18.4)
STAGE AT DIAGNOSIS
 Early 29 (12.7) 71 (29.7) <0.0001
 Locally advanced 47 (20.5) 67 (28)
 Metastatic 153 (66.8) 101 (42.3)
TREATMENT
 Surgery only 4(1.7) 21(8.8) < 0.0001
 AC only 139(60.7) 99(41.4)
 Surgery +AC 12(5.2) 39(16.3)
 Multimodal 74(32.3) 80(33.5)
PS
 0 1(0.4) 52(21.8) < 0.0001
 1-2 206(90) 140(58.6)
 > 2 22(9.6) 47(19.7)